iShares Genomics Immunology and Healthcare ETF(IDNA · ETF)

ETF quote, holdings, sector allocation, technicals, and options analytics.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

IDNA $32.35
Snapshot
$32.35
52-Week Range
$20.93 – $34.97
YTD
+23.38%
IV Rank (30D)
24.92
Straddle Price
$2.12
P/C Vol Ratio
0.01
Info

iShares Genomics Immunology and Healthcare ETF (IDNA) ETF

Exchange
ARCX
Inception
2019-06-11
Has Options
Yes
ETF Profile
holdings as of 2026-07-22
Holdings
62
AUM
$191.2M
Provider
iShares (BlackRock)
Inception
2019-06-11
Exchange
ARCX
Data As Of
2026-07-22
Expense Ratio
Dividend Yield
0.87%
Distribution
Semi-Annual
Recent distributions
Ex-Date Pay Date Amount Type
2026-06-15 2026-06-18 $0.1254 CD
2025-12-16 2025-12-19 $0.1555 CD
2025-06-16 2025-06-20 $0.1529 CD
2024-12-17 2024-12-20 $0.1111 CD
2024-06-11 2024-06-17 $0.1114 CD
2023-12-20 2023-12-27 $0.1692 CD
Asset Allocation
Top Holdings
top 50 of 62 holdings
Symbol Name Weight % Asset Class Country
TWST TWIST BIOSCIENCE CORP 4.92% Equity (US) United States
BAYN BAYER AG 4.64% Equity (Foreign) Germany
RVMD REVOLUTION MEDICINES INC 4.44% Equity (US) United States
MRNA MODERNA INC 4.43% Equity (US) United States
GMAB GENMAB 4.28% Equity (Foreign) Denmark
INCY INCYTE CORP 4.09% Equity (US) United States
TAKEDA PHARMACEUTICAL LTD 4.01% Equity (Foreign) Japan
VRTX VERTEX PHARMACEUTICALS INC 3.83% Equity (US) United States
MRK MERCK & CO INC 3.82% Equity (US) United States
EXEL EXELIXIS INC 3.78% Equity (US) United States
BNTX BIONTECH SE ADR 3.77% Equity (Foreign) Germany
REGN REGENERON PHARMACEUTICALS INC 3.71% Equity (US) United States
IPN IPSEN SA 3.67% Equity (Foreign) France
ROP ROCHE PS PAR AG 3.59% Equity (Foreign) Switzerland
GSK GLAXOSMITHKLINE 3.56% Equity (Foreign) United Kingdom
SAN SANOFI SA 3.52% Equity (Foreign) France
IDYA IDEAYA BIOSCIENCES INC 3.30% Equity (US) United States
IBRX IMMUNITYBIO INC 3.21% Equity (US) United States
RCUS ARCUS BIOSCIENCES INC 2.85% Equity (US) United States
IOVA IOVANCE BIOTHERAPEUTICS INC 2.28% Equity (US) United States
CAI CARIS LIFE SCIENCES INC 2.14% Equity (US) United States
ONO PHARMACEUTICAL LTD 1.89% Equity (Foreign) Japan
NUVB NUVATION BIO INC CLASS A 1.84% Equity (US) United States
CRSP CRISPR THERAPEUTICS AG 1.54% Equity (US) United States
ABCL ABCELLERA BIOLOGICS INC 1.53% Equity (Foreign) Canada
VIR VIR BIOTECHNOLOGY INC 1.41% Equity (US) United States
NVAX NOVAVAX INC 1.41% Equity (US) United States
GENFLEET THERAPEUTICS (SHANGHAI) I 1.03% Equity (Foreign) China
KURA KURA ONCOLOGY INC 1.03% Equity (US) United States
JANX JANUX THERAPEUTICS INC 1.01% Equity (US) United States
CRVS CORVUS PHARMACEUTICALS INC 1.00% Equity (US) United States
PSNL PERSONALIS INC 0.88% Equity (US) United States
RIGL RIGEL PHARMACEUTICALS INC 0.77% Equity (US) United States
SUNSHINE LAKE PHARMA LTD CLASS H 0.76% Equity (Foreign) China
CTMX CYTOMX THERAPEUTICS INC 0.65% Equity (US) United States
VSTM VERASTEM INC 0.55% Equity (US) United States
NTLA INTELLIA THERAPEUTICS INC 0.54% Equity (US) United States
SHANGHAI HENLIUS BIOTECH INC H 0.53% Equity (Foreign) China
DSGN DESIGN THERAPEUTICS INC 0.50% Equity (US) United States
XNCR XENCOR INC 0.50% Equity (US) United States
OCGN OCUGEN INC 0.49% Equity (US) United States
PACB PACIFIC BIOSCIENCES OF CALIFORNIA 0.45% Equity (US) United States
VLA VALNEVA 0.45% Equity (Foreign) France
DNA GINKGO BIOWORKS HOLDINGS INC CLASS 0.41% Equity (US) United States
ALVO ALVOTECH SA 0.41% Equity (Foreign) Iceland
ABCLON INC 0.24% Equity (Foreign) Korea (South)
PRME PRIME MEDICINE INC 0.11% Equity (US) United States
XTSLA BLK CSH FND TREASURY SL AGENCY 0.09% Cash/Money Market United States
USD USD CASH 0.06% Cash/Money Market United States
JPY JPY CASH 0.04% Cash/Money Market Japan
Geographic Breakdown
Non-Equity Breakdown
iShares Genomics Immunology and Healthcare ETF · NPORT-P period 2026-07-31 (filed 2026-03-25)
Net assets: $143M · 63 total positions · equity 95.36% · non-equity 21.12%
Non-equity holdings — 13 positions, 21.12% of NAV
Category Weight Value Positions
Short-term investment 16.60% $23.7M 2
Other 4.52% $6.4M 10
Derivative (equity) 0.00% $86 1
Chart
Seasonality
MonthAvg ReturnYears of Data
Jan -0.86% 6
Feb -1.98% 6
Mar -1.82% 6
Apr -1.77% 6
May +1.55% 6
Jun +3.54% 6
Jul +1.70% 6
Aug -0.83% 5
Sep -5.01% 5
Oct -0.90% 5
Nov +4.51% 5
Dec -3.30% 5
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $33.35
SMA 50: $31.12
SMA 200: $28.68
Current: $32.35
EMA 12: $32.80
EMA 26: $32.46
MACD: 0.3446 | Signal: -0.2891
BULLISH
ADX (14): 21.87
WEAK TREND
+DI: 18.59
−DI: 22.75
Momentum Oscillators
RSI (14): 49.35
NEUTRAL
Stoch %K: 15.04
Stoch %D: 14.43
Williams %R: -86.73
Volume & Volatility
BB Upper: $35.05
BB Lower: $31.66
NEUTRAL
OBV: 1,366,741
Vol SMA 20: 74,289
Vol ROC: -8.02%
ATR: $0.69
True Range: $0.66
HV 20: 26.5%
HV 30: 25.0%
HV 60: 25.5%

Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-07-25T00:00:00 – 2026-07-23T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Options Activity
IV Rank (30D)
24.92
IV Rank (7D)
24.92
Avg IV
35.7%
Straddle (30D)
$2.12
Straddle (7D)
$2.12
P/C Volume
0.01
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
pts EXTREME
ATM — / Wing —
30 DTE / 10d
pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
0.99
Correlation (SPY)
50.0%
0.25
Ann. Volatility
25.1%
SPY Volatility
12.7%

Moderate volatility - stock generally follows market

Beta & Alpha Over Time
Constituent Performance

Click any bar to view the full quote for that stock.

Constituents
Symbol Name Weight % Price 1 Day 1 Week 1 Month